Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

BIOLASE Technology, Inc. (BLTI) Continues to Soar on Launch Laser Technology Device

|Includes: Biolase, Inc. (BIOL)

Shares of BIOLASE Technology Inc., the world’s leading dental laser manufacturer and distributor, are soaring for a second day after the company announced the launch of its Waterlase® iPlus™ System dual-wavelength all-tissue laser. The hype signifies the device’s status as the first major breakthrough in all-tissue laser technology since the Waterlase MD™ was introduced in 2005.

The new iPlus can cut all tissue types twice as fast as current laser systems, with no pain or discomfort, and eliminates the risk of cross-contamination associated with conventional drills. BIOLASE’s iPlus not only addresses important needs for the next generation of laser dentists, it also delivers more power, control and versatility for experienced laser dentists.

“The iPlus represents a major leap in the development of all-tissue dental lasers. Cutting teeth at the speed of the mechanical drill without sacrificing patient comfort has always been our goal at BIOLASE. It was a tremendous challenge for us, which took several years to develop,” BIOLASE Chief Technology Officer Dmitri Boutoussov, PhD stated in the press release.

Dr. Boutoussov said BIOLASE’s patent-pending technology, 2R Powered, will allow the company to build an Er;Cr:YSGG laser that delivers the highest pulse repetition rate and highest pulse energy at short pulses among all Erbium-based, 3-micron lasers in the industry. The cutting-edge technology allows dentists to quickly remove hard tooth tissue with no discomfort to the patient, leaving a smooth surface finish.

“The technology also opens a great opportunity to explore non-dental applications in medicine, which require fast and smooth cutting of both soft tissue and bone, coverage of larger surface areas (like skin or wounds), and where the delivery of laser radiation to treatment site through a flexible fiber is a must-have,” Dr. Boutoussov stated.

Chairman and CEO Federico Pignatelli said the iPlus will significantly affect the company’s future sales.

“The iPlus is our new flagship laser product and will have a substantial impact on our sales in 2011 and beyond. It is the most advanced — yet most intuitive — dental laser ever conceived. With the Intuitive Power of the iPlus, dentists will be able to completely focus on dentistry, while the iPlus handles the technical laser details. I’m extremely proud of the job done by our R&D team under the leadership of Dr. Boutoussov, to deliver the perfect product for the rapidly growing worldwide dental laser market,” Pignatelli stated. “We have received full FDA clearance and will begin taking orders next week for delivery this quarter.”

For more information visit or

Please see disclaimer on QualityStocks website: